Molecular Glue Discovery: Current and Future Approaches

被引:45
作者
Dewey, Jeffrey A. [1 ]
Delalande, Cleïmence [2 ]
Azizi, Saara-Anne [3 ]
Lu, Vivian [2 ]
Antonopoulos, Dionysios [1 ]
Babnigg, Gyorgy [1 ]
机构
[1] Argonne Natl Lab, Biosci Div, Lemont, IL 60439 USA
[2] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
[3] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA
关键词
PROTEIN-PROTEIN INTERACTIONS; E3 UBIQUITIN LIGASE; TOPOISOMERASE-II; STRUCTURAL BASIS; TRANSCRIPTION FACTOR; POSE PREDICTION; DRUG DISCOVERY; INHIBITORS; ACTIVATION; COMPLEX;
D O I
10.1021/acs.jmedchem.3c00449
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The intracellular interactions ofbiomolecules can bemaneuveredto redirect signaling, reprogram the cell cycle, or decrease infectivityusing only a few dozen atoms. Such "molecular glues,"which can drive both novel and known interactions between proteinpartners, represent an enticing therapeutic strategy. Here, we reviewthe methods and approaches that have led to the identification ofsmall-molecule molecular glues. We first classify current FDA-approvedmolecular glues to facilitate the selection of discovery methods.We then survey two broad discovery method strategies, where we highlightthe importance of factors such as experimental conditions, softwarepackages, and genetic tools for success. We hope that this curationof methodologies for directed discovery will inspire diverse researchefforts targeting a multitude of human diseases.
引用
收藏
页码:9278 / 9296
页数:19
相关论文
共 128 条
  • [1] Stabilization of protein-protein interactions in drug discovery
    Andrei, Sebastian A.
    Sijbesma, Eline
    Hann, Michael
    Davis, Jeremy
    O'Mahony, Gavin
    Perry, Matthew W. D.
    Karawajczyk, Anna
    Eickhoff, Jan
    Brunsveld, Luc
    Doveston, Richard G.
    Milroy, Lech-Gustav
    Ottmann, Christian
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (09) : 925 - 940
  • [2] Thalidomide analogues as anticancer drugs
    Aragon-Ching, Jeanny B.
    Li, Haiqing
    Gardner, Erin R.
    Figg, William D.
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (02) : 167 - 174
  • [3] Arbuck S G, 1993, J Natl Cancer Inst Monogr, P11
  • [4] Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
    Arkin, MR
    Wells, JA
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) : 301 - 317
  • [5] A practical guide to large-scale docking
    Bender, Brian J.
    Gahbauer, Stefan
    Luttens, Andreas
    Lyu, Jiankun
    Webb, Chase M.
    Stein, Reed M.
    Fink, Elissa A.
    Balius, Trent E.
    Carlsson, Jens
    Irwin, John J.
    Shoichet, Brian K.
    [J]. NATURE PROTOCOLS, 2021, 16 (10) : 4799 - 4832
  • [6] Protein-Small Molecule Interactions in Native Mass Spectrometry
    Bennett, Jack L.
    Nguyen, Giang T. H.
    Donald, William A.
    [J]. CHEMICAL REVIEWS, 2022, 122 (08) : 7327 - 7385
  • [7] Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO
  • [8] 2-5
  • [9] FDA approved drugs complexed to their targets: evaluating pose prediction accuracy of docking protocols
    Bohari, Mohammed H.
    Sastry, G. Narahari
    [J]. JOURNAL OF MOLECULAR MODELING, 2012, 18 (09) : 4263 - 4274
  • [10] Comparative study of the p53-mdm2 and p53-MDMX interfaces
    Böttger, V
    Böttger, A
    Garcia-Echeverria, C
    Ramos, YFM
    van der Eb, AJ
    Jochemsen, AG
    Lane, DP
    [J]. ONCOGENE, 1999, 18 (01) : 189 - 199